The responses may in fact influence AD pathogenesis since CatB degrades Aβ42 through C-terminal truncation [31, 34, 35], and such degradation was blocked by the selective CatB inhibitor CA074 [31]. The gene discussed is TYRP1; the disease is Alzheimer disease.